- Trials with a EudraCT protocol (136)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
136 result(s) found for: VLDL.
Displaying page 1 of 7.
EudraCT Number: 2017-001899-32 | Sponsor Protocol Number: RESINFENOL | Start Date*: 2017-08-17 |
Sponsor Name:Dr. Abelardo Aguilera Peralta | ||
Full Title: Crossover and randomized clinical trial on the effect of Resincolestiramine in the intestinal absorption of new uremic toxins in patients in hemodialysis with chronic renal insufficiency | ||
Medical condition: Chronic renal insufficiency | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2020-000831-34 | Sponsor Protocol Number: GoforGH | Start Date*: 2022-01-11 |
Sponsor Name:Medical University of Vienna | ||
Full Title: InvestiGating the rOle of Growth Hormone in hepatic lipid metabolism in humans | ||
Medical condition: Healthy subjects | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-003014-22 | Sponsor Protocol Number: Thalamus_V3 | Start Date*: 2018-06-25 |
Sponsor Name:Medical University of Vienna | ||
Full Title: The role of leptin in regulating hepatic lipid metabolism in humans | ||
Medical condition: lipodystrophy patients, patients after liver transplantation and healthy controls | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-002889-11 | Sponsor Protocol Number: D3560C00071 | Start Date*: 2005-11-04 |
Sponsor Name:AstraZeneca AB | ||
Full Title: An 18-Week, Randomized, Multicenter, Phase IIIb, Double-Blind, Crossover Study, Followed by an 18-Week Open-Label Period to Evaluate the Efficacy and Safety of the Lipid-Regulating Agents, Rosuvast... | ||
Medical condition: Dysbetalipoproteinemia (Fredrickson Type III Hyperlipoproteinemia) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-003807-19 | Sponsor Protocol Number: 0653A-071 | Start Date*: 2004-12-21 | |||||||||||
Sponsor Name:Merck & Co., Inc. | |||||||||||||
Full Title: A Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin and Fenofibrate Coadministration in Patients With Mixed Hyperlipidemia | |||||||||||||
Medical condition: Mixed hyperlipidemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) AT (Completed) GB (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000808-16 | Sponsor Protocol Number: C11palmitatmetformin | Start Date*: 2013-03-27 | |||||||||||
Sponsor Name:Aarhus University Hospital | |||||||||||||
Full Title: Effects of metformin on hepatic free fatty acid metabolism in type 2 diabetes asssessed by positron emission tomography | |||||||||||||
Medical condition: Type 2 diabetes and dyslipidemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004682-14 | Sponsor Protocol Number: OM-EPA-011 | Start Date*: 2014-04-15 | |||||||||||
Sponsor Name:Omthera Pharmaceuticals, Inc. | |||||||||||||
Full Title: A 12-Week, Randomized, Double-Blind, Olive Oil-Controlled Phase 3 Study to Assess the Efficacy and Safety of EPANOVA™ in Subjects With Severe Hypertriglyceridemia (EVOLVE II) | |||||||||||||
Medical condition: Severe hypertriglyceridemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) CZ (Completed) NL (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-016382-29 | Sponsor Protocol Number: P1736-05/34/09 | Start Date*: 2009-11-06 |
Sponsor Name:Piramal Life Sciences Limited | ||
Full Title: A Phase II, 12-Week Randomised, Double-Blind, Placebo-Controlled, Proof of Concept Study to Evaluate Safety, Tolerability, Pharmacokinetics and Effect On Glycemic Control of P1736-05 in Subjects wi... | ||
Medical condition: Diabetes mellitus, type 2 (Blood Glucose Lowering Effect)/ | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) HU (Completed) CZ (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-023742-79 | Sponsor Protocol Number: AEG 733-012 | Start Date*: 2011-03-25 | |||||||||||
Sponsor Name:AEGERION PHARMACEUTICALS | |||||||||||||
Full Title: A Phase III, Long Term, Open Label, Follow on Study of Microsomal Triglyceride Transfer Protein (MTP) Inhibitor ‘lomitapide’ (AEGR-733) in Patients with Homozygous Familial Hypercholesterolemia | |||||||||||||
Medical condition: Homozygous Familial Hypercholesterolemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-002715-10 | Sponsor Protocol Number: FAR-NP-2018-01 | Start Date*: 2019-02-08 |
Sponsor Name:Elisabet Leiva Badosa. Phamacy Department. Hospital Universitari de Bellvitge | ||
Full Title: RANDOMIZED, DOUBLE-BLIND, PILOT CLINICAL TRIAL TO COMPARE THE EFFICACY AND SAFETY OF FISH OIL-BASED INTRAVENOUS LIPID EMULSIONS IN HOSPITALIZED ADULT PATIENTS TREATED WITH TOTAL PARENTERAL NUTRITIO... | ||
Medical condition: Hypertriglyceridemia is a frequent metabolic complication associated with the administration of lipidic emulsion in total parenteral nutrition. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-007058-36 | Sponsor Protocol Number: 733-005 | Start Date*: 2009-06-25 | |||||||||||
Sponsor Name:Aegerion Pharmaceuticals | |||||||||||||
Full Title: A Phase III Study of Microsomal Triglyceride Transfer Protein (MTP) Inhibitor AEGR-733 in Patients with Homozygous Familial Hypercholesterolemia on Current Lipid-lowering Therapy | |||||||||||||
Medical condition: Homozygous Familial Hypercholesterolemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-002826-22 | Sponsor Protocol Number: Tobeallocatedlater | Start Date*: 2013-10-17 |
Sponsor Name:University of Surrey | ||
Full Title: The effect of Lixisenatide on triacylglycerol and glucose metabolism in patients with type 2 diabetes | ||
Medical condition: Type 2 Diabetes | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-003626-26 | Sponsor Protocol Number: 01-05-TL-475-016 | Start Date*: 2006-06-14 | |||||||||||
Sponsor Name:Takeda Europe R&D Centre Ltd | |||||||||||||
Full Title: A double-blind, placebo-controlled, randomized study to evaluate the efficacy and safety of TAK-475 or placebo when co-administered with current lipid-lowering therapy in subjects with homozygous f... | |||||||||||||
Medical condition: Treatment of primary dyslipidemia | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004681-15 | Sponsor Protocol Number: KIMCL_TS_2011-09 | Start Date*: 2011-11-09 |
Sponsor Name:Medizinische Universität Graz | ||
Full Title: Effects of the activation of peroxisome proliferator-activated receptors in patients with primary biliary cirrhosis | ||
Medical condition: Up to 67% of PBC patients have an incomplete biochemical response to UDCA and remain at increased risk for progression to cirrhosis and liver-related death. In this study we will prospectively exam... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-024064-18 | Sponsor Protocol Number: OM-EPA-003 | Start Date*: 2011-03-22 | |||||||||||
Sponsor Name:Omthera Pharmaceutical Inc. | |||||||||||||
Full Title: Efficacy and Safety of Epanova® in Severe Hypertriglyceridemia | |||||||||||||
Medical condition: Severe hypertriglyceridemia defined as serum triglyceride (TG) values ≥500 and <2000 mg/dL (≥5.65 mmol/L and <22.60 mmol/L). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002351-34 | Sponsor Protocol Number: V1.0 | Start Date*: 2013-02-21 |
Sponsor Name:Medizinische Universitaet Wien, Univ.Klinik f.Innere Medizin III, Abteilung fuer Gastroenterologie und Hepatologie | ||
Full Title: Effects of oral and intravenous lipid load on Hepatitis C virus concentrations in serum and lipoprotein subfractions | ||
Medical condition: chronic hepatitis C | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-019720-32 | Sponsor Protocol Number: P-100820-01 | Start Date*: 2010-07-08 | |||||||||||
Sponsor Name:Ferrer Internacional, S.A. | |||||||||||||
Full Title: Cardiovascular Fixed Combination Pill ASR: ensayo clínico farmacodinámico de la combinación a dosis fijas de ácido acetilsalicílico, simvastatina, y ramipril (Cardiovascular Polypill); Colesterol L... | |||||||||||||
Medical condition: terapia sustitutiva para la prevención de accidentes cardiovasculares Substitution therapy to prevent cardiovascular accidents | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001489-34 | Sponsor Protocol Number: TAK-475_306 | Start Date*: 2007-10-01 | |||||||||||
Sponsor Name:Takeda Global Research & Development Centre (Europe) Ltd | |||||||||||||
Full Title: A Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Lapaquistat Acetate 50 mg versus Placebo in Subjects with Hypercholesterolemia, With an Optional Open-Label Extension | |||||||||||||
Medical condition: Subjects With Hypercholesterolemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) LV (Completed) EE (Prematurely Ended) HU (Prematurely Ended) ES (Completed) NL (Prematurely Ended) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-002315-25 | Sponsor Protocol Number: TAK-475/EC303 | Start Date*: 2005-12-15 | |||||||||||
Sponsor Name:Takeda Europe R&D Centre Ltd | |||||||||||||
Full Title: A double-blind, double dummy, randomized, parallel group, multi-centre Phase III study to evaluate the efficacy and safety of TAK-475 100 mg and TAK-475 100 mg administered in combination with ezet... | |||||||||||||
Medical condition: Treatment of patients with primary dyslipidaemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) EE (Completed) FI (Completed) LV (Completed) LT (Completed) HU (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003818-26 | Sponsor Protocol Number: K-877-302 | Start Date*: 2017-03-16 | |||||||||||
Sponsor Name:Kowa Research Institute, Inc. | |||||||||||||
Full Title: Pemafibrate to Reduce cardiovascular OutcoMes by reducing triglycerides IN patiENts with diabeTes (PROMINENT) | |||||||||||||
Medical condition: Reduction of cardiovascular events in patients with Type II Diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) NL (Prematurely Ended) BG (Prematurely Ended) DE (Completed) DK (Completed) GB (GB - no longer in EU/EEA) ES (Prematurely Ended) HU (Completed) CZ (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
